RICE HALL JAMES & ASSOCIATES, LLC - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 2 filers reported holding NPS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$10,860,000
+100.4%
303,608
+45.7%
0.66%
+74.3%
Q3 2014$5,418,000
+8.3%
208,385
+37.7%
0.38%
+12.2%
Q2 2014$5,003,000
+16.9%
151,369
+5.9%
0.34%
+7.3%
Q1 2014$4,280,000
-9.2%
142,992
-8.0%
0.31%
-7.6%
Q4 2013$4,716,000
+156.9%
155,348
+169.1%
0.34%
+93.2%
Q3 2013$1,836,000
+60.5%
57,732
-23.7%
0.18%
+55.8%
Q2 2013$1,144,00075,6810.11%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 424,175$12,695,0005.06%
Opaleye Management Inc. 150,000$4,490,0003.32%
OAK RIDGE INVESTMENTS LLC 2,795,331$83,664,0002.10%
SCHOLTZ & COMPANY, LLC 60,350$1,806,0001.94%
SECTORAL ASSET MANAGEMENT INC 1,408,729$42,163,0001.73%
First Light Asset Management, LLC 79,099$2,367,0001.68%
FCG ADVISORS, LLC 71,146$2,129,0001.51%
Rhenman & Partners Asset Management AB 166,970$4,997,0001.50%
BENDER ROBERT & ASSOCIATES 73,611$2,203,0001.48%
Eventide Asset Management 283,900$8,497,0001.32%
View complete list of NPS PHARMACEUTICALS INC shareholders